Patient No. | Age (y) | Sex | Local Recur-rence | Time to Local Recurrence (m) | Follow-up Period (m) | TNM Classification (UICC, 7th edition) | WHO Histological Classification | Radiotherapy | Chemo-therapy | Number of Voxels | Number of Overlapped Voxels | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T | N | M | Stage | Dose (Gy) | Frac-tion | ||||||||||
1 | 57 | M | + | 5 | 3 | 2 | 0 | III | NA | 70 | 35 | + | 13,758 | 4410 | |
2 | 45 | F | + | 7 | 2 | 2 | 0 | III | III | 70 | 35 | + | 10,954 | 1679 | |
3 | 61 | M | + | 9 | 2 | 2 | 0 | III | II or III | 70 | 35 | + | 2235 | 906 | |
4 | 48 | M | + | 9 | 1 | 1 | 0 | II | III | 70 | 35 | + | 1867 | 868 | |
5 | 66 | M | + | 11 | 3 | 0 | 0 | III | II or III | 70 | 35 | + | 11,981 | 4116 | |
6 | 61 | M | + | 16 | 4 | 0 | 0 | IVA | I | 70 | 35 | + | 12,388 | 2187 | |
7 | 59 | F | + | 23 | 4 | 1 | 0 | IVA | II | 66 | 33 | + | 18,197 | 153 | |
8 | 40 | M | + | 30 | 3 | 1 | 0 | III | II or III | 70 | 35 | + | 18,681 | 462 | |
9 | 66 | F | + | 46 | 3 | 0 | 0 | III | III | 70 | 35 | + | 3537 | 1832 | |
1 | 67 | M | – | 37 | 4 | 2 | 0 | IVA | II or III | 70 | 35 | + | 11,976 | ||
2 | 61 | M | – | 40 | 2 | 2 | 0 | III | NA | 70 | 35 | + | 5610 | ||
3 | 45 | F | – | 41 | 4 | 1 | 0 | IVA | III | 70 | 35 | + | 18,610 | ||
4 | 44 | M | – | 43 | 3 | 2 | 0 | III | III | 70 | 35 | + | 8478 | ||
5 | 53 | M | – | 44 | 3 | 2 | 0 | III | II or III | 70 | 35 | + | 30,802 | ||
6 | 63 | M | – | 45 | 1 | 2 | 0 | III | II or III | 70 | 35 | + | 4116 | ||
7 | 77 | M | – | 48 | 1 | 0 | 0 | I | NA | 70 | 35 | – | 3756 | ||
8 | 50 | F | – | 50 | 2 | 2 | 0 | III | I | 70 | 35 | + | 39,955 | ||
9 | 52 | F | – | 53 | 1 | 1 | 0 | II | II or III | 70 | 35 | + | 1220 | ||
10 | 52 | M | – | 54 | 3 | 2 | 0 | III | II or III | 70 | 35 | + | 16,309 | ||
11 | 77 | M | – | 60 | 2 | 2 | 0 | III | II or III | 70 | 35 | – | 5498 | ||
12 | 53 | M | – | 61 | 2 | 1 | 0 | II | II or III | 70 | 35 | + | 2660 |